ingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial
- Conditions
- novel coronavirus pneumonia (COVID-19)Quality of life and mental health status
- Registration Number
- ITMCTR2000003245
- Lead Sponsor
- The First Afflicated Hospital of Guangzhou University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. in line with epidemiological history survey and negative forCOVID-19 RNA screening
2. in line with inclusion criteria and voluntarily receive fire needle treatment
3. Aged 18 to 65 years old;
4. Quality of life score<=37;
5. Voluntary participation in this study and sign informed consent.
1. People who are taking anticoagulant drugs (such as warfarin), or have received other related treatments, may affect the indicators of this study;
2. Pregnant women;
3. Those who cannot tolerate fire needles due to allergies, stress, etc.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.